Global Health Ltd
Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.[1]
- Market Cap ₹ 31,809 Cr.
- Current Price ₹ 1,184
- High / Low ₹ 1,389 / 936
- Stock P/E 63.8
- Book Value ₹ 130
- Dividend Yield 0.00 %
- ROCE 20.7 %
- ROE 15.7 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 37.1% CAGR over last 5 years
Cons
- Stock is trading at 9.09 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap BSE Allcap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
1,277 | 1,343 | 1,441 | 1,472 | 1,227 | 1,765 | 1,974 | 2,280 | 3,204 | |
1,158 | 1,218 | 1,297 | 1,253 | 1,054 | 1,384 | 1,551 | 1,777 | 2,439 | |
Operating Profit | 119 | 125 | 144 | 219 | 173 | 381 | 423 | 503 | 765 |
OPM % | 9% | 9% | 10% | 15% | 14% | 22% | 21% | 22% | 24% |
67 | 49 | 64 | 43 | 28 | 35 | 47 | 103 | 41 | |
Interest | 19 | 24 | 21 | 33 | 29 | 33 | 32 | 30 | 33 |
Depreciation | 77 | 86 | 91 | 99 | 88 | 87 | 86 | 87 | 150 |
Profit before tax | 89 | 64 | 97 | 131 | 84 | 296 | 352 | 489 | 623 |
Tax % | 39% | 42% | 35% | 22% | 32% | 26% | 25% | 26% | 26% |
54 | 37 | 63 | 103 | 57 | 219 | 263 | 361 | 462 | |
EPS in Rs | 11.21 | 7.70 | 12.81 | 20.82 | 11.55 | 8.64 | 9.82 | 13.44 | 17.18 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 17% |
3 Years: | 22% |
TTM: | 41% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 37% |
3 Years: | 32% |
TTM: | 38% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -1% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 13% |
3 Years: | 14% |
Last Year: | 16% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 48 | 81 | 49 | 49 | 50 | 51 | 54 | 54 | 54 |
Reserves | 1,070 | 1,141 | 1,230 | 1,341 | 1,434 | 1,689 | 2,435 | 2,795 | 3,444 |
215 | 168 | 168 | 51 | 228 | 308 | 288 | 260 | 223 | |
303 | 318 | 310 | 517 | 291 | 314 | 402 | 414 | 720 | |
Total Liabilities | 1,637 | 1,709 | 1,758 | 1,958 | 2,002 | 2,361 | 3,179 | 3,523 | 4,441 |
966 | 1,162 | 869 | 929 | 851 | 827 | 810 | 841 | 1,865 | |
CWIP | 8 | 7 | 5 | 3 | 4 | 6 | 75 | 184 | 454 |
Investments | 21 | 0 | 356 | 500 | 626 | 734 | 765 | 790 | 366 |
642 | 540 | 528 | 525 | 521 | 794 | 1,529 | 1,708 | 1,757 | |
Total Assets | 1,637 | 1,709 | 1,758 | 1,958 | 2,002 | 2,361 | 3,179 | 3,523 | 4,441 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
124 | 152 | 193 | 201 | 235 | 431 | 341 | 528 | ||
-112 | -104 | -45 | -250 | -313 | -257 | -699 | -638 | ||
-6 | -49 | -56 | -37 | 98 | 404 | -66 | -94 | ||
Net Cash Flow | 6 | -1 | 92 | -86 | 20 | 577 | -424 | -205 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 31 | 41 | 42 | 37 | 39 | 36 | 32 | 31 | 33 |
Inventory Days | 36 | 26 | 26 | 37 | 39 | 33 | 34 | 30 | 24 |
Days Payable | 132 | 124 | 142 | 135 | 134 | 84 | 113 | 93 | 81 |
Cash Conversion Cycle | -66 | -56 | -74 | -61 | -56 | -16 | -48 | -32 | -24 |
Working Capital Days | -23 | -4 | -7 | -11 | -10 | 8 | -13 | -1 | -8 |
ROCE % | 6% | 8% | 11% | 7% | 17% | 16% | 18% | 21% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
1d - For Schedule of Analysts/Institutional Investors Meeting
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
1d - Scheduled investor meetings on May 26 and 29, 2025; no price sensitive info to be shared.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
1d - For Schedule of Analysts/Institutional Investors Meeting
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
1d - Medanta FY25 earnings: 13% revenue growth, INR 4000 Cr capex for 3000+ beds expansion over 3-4 years.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
16 May - Investor Presentation for fourth quarter and financial year ended March 31, 2025 results.
Annual reports
Concalls
-
May 2025Transcript PPT
-
May 2025TranscriptNotesPPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Dec 2022TranscriptNotesPPT
Hospital Count[1] Global Health operates five hospitals under the "Medanta" brand in Gurugram, Indore, Ranchi, Lucknow, and Patna, with one more hospital under construction in Noida. The company provides services in over 30 medical specialties, employing 1,750+ doctors across a total area of 4.7 million square feet.
The operational hospitals have 3,008 installed beds. In addition, Global Health runs 6 multi-specialty clinics in locations such as DLF Cybercity Gurugram, Delhi Airport, South Delhi, Darbhanga, Patna, and Subhash Chowk Gurugram.[2]